Skip to main content

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

NOVEL TREATMENT FOR BREAST CANCER: TRUNCATED GALECTIN-3

Award Number: R43CA092801
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/10/2001
PERIOD OF PERFORMANCE END DATE: 06/30/2003

Group Awards By:

View Award Description

NOVEL TREATMENT FOR BREAST CANCER: TRUNCATED GALECTIN-3


	Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

	Issue Date FY: 2002 ( Subtotal = $255,495 )
	2002	2002	MANDALMED, INC	2645 OCEAN AVENUE SUITE 302	SAN FRANCISCO	CA	94132	SAN FRANCISCO	USA	Cancer Treatment Research	000	2	6/1/2002	NON-COMPETING CONTINUATION	$255,495
															Subtotal = $255,495

	Issue Date FY: 2001 ( Subtotal = $236,893 )
	2001	2001	MANDALMED, INC	2645 OCEAN AVENUE SUITE 302	SAN FRANCISCO	CA	94132	SAN FRANCISCO	USA	Cancer Treatment Research	000	1	7/10/2001	NEW	$236,893
															Subtotal = $236,893

	Grand Total All Awards = $492,388

Hide

Top